https://www.selleckchem.com/pr....oducts/santacruzamat
83; 95% CI 0.68-1.03), intracranial bleeding (HR 0.66; 95% CI 0.34-1.3, gastrointestinal bleeding (HR 0.88; 95% CI 0.60-1.3, and bleeding on other clinically relevant sites (HR 0.89; 95% CI 0.60-1.31). In the subgroup analyses stratified by gender and diabetes severity, the risk for stroke and bleeding remained consistent. DOACs are effective and safe alternatives to warfarin for the prevention of stroke in AF patients with T2DM. DOACs are effective and safe alternatives to warfarin for the prevention of stroke in
Like
Comment
Share
